Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abiocode is a private California-based life science tools company focused on high-throughput antibody production and related biomedical research reagents. The company develops and sells research antibodies, including polyclonal, monoclonal, ChIP-grade, plant, and paired antibody products, and also offers custom antibody generation services. Abiocode states that it uses a proprietary antibody-production technology to deliver high-quality and cost-effective reagents for the biomedical research community. In addition to catalog antibodies, the company has described efforts to develop antibody arrays and ELISA kits for disease diagnosis and basic research. Overall, Abiocode appears to operate as a commercial research-tools supplier rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abiocode.